Diagnosis & Disease Information

First Ever Drug for Duchenne Muscular Dystrophy Approved by FDA

September 20, 2016

The FDA has just approved the drug, Exondys 51, to treat patients with a mutation of the dystrophin gene amenable to exon 51 skipping in DMD.

Next post in Medicine

Aggressive Efforts in BP Control in High Risk Populations Could Prevent 100,000 Deaths a Year